Literature DB >> 23927825

Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia.

Chih-Yung Chiu1, Chih-Jung Chen2, Kin-Sun Wong3, Ming-Han Tsai4, Cheng-Hsun Chiu2, Yhu-Chering Huang5.   

Abstract

BACKGROUND/
PURPOSE: Coinfection of Mycoplasma pneumoniae is not uncommon in children with respiratory syndromes. The purpose of this study was to investigate the impact of bacterial and viral coinfection on mycoplasmal pneumonia in hospitalized children with community-acquired pneumonia (CAP).
METHODS: Children coinfected with M. pneumoniae in a prospective study of the etiology of CAP at a tertiary pediatric facility Children's Hospital were enrolled and retrospectively reviewed. The data of clinical characteristics, complications, and outcomes of these children were collected and analyzed.
RESULTS: A total of 59 children were enrolled and stratified into three groups: M. pneumoniae infection alone (n = 31), M. pneumoniae with Streptococcus pneumoniae coinfection (n = 9), and M. pneumoniae with virus coinfection (n = 19). As compared with children infected with M. pneumoniae alone, coinfection of children with S. pneumoniae was more likely to occur under the age of 5 years with a longer duration of fever and hospital stay. Furthermore, total leukocyte count and serum C-reactive protein level were also significantly higher in these children (p < 0.01). However, no significant difference in clinical characteristics, complications, and outcomes was observed between the patients infected with either M. pneumoniae alone or with virus coinfection.
CONCLUSION: In children with CAP, the influence on the clinical outcomes of M. pneumoniae infection may be heavily dependent on the coinfected pathogen. A potential coexistence of M. pneumoniae infection should be considered in children with features suggesting typical bacterial pneumonia.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Coinfection; Mycoplasma pneumoniae; Outcomes

Mesh:

Year:  2013        PMID: 23927825     DOI: 10.1016/j.jmii.2013.06.006

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  21 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Severe Mycoplasma Pneumonia in Child with Bilateral Parapneumonic Effusion Successfully Treated with Integrated Chinese and Western Medicine: A Case Report.

Authors:  Wen-Ying Zeng; Yan Li; Zhi-Lan Xu; Xiao-Lei Xie; Feng-Qin Xu; Na Rui
Journal:  Chin J Integr Med       Date:  2018-02-17       Impact factor: 1.978

Review 3.  Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management.

Authors:  Lin Tong; Shumin Huang; Chen Zheng; Yuanyuan Zhang; Zhimin Chen
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

4.  The Prevalence of Mycoplasma Pneumoniae Among Children in Beijing Before and During the COVID-19 Pandemic.

Authors:  Yuan Cheng; Yijing Cheng; Shuzhi Dai; Dongqing Hou; Menglei Ge; Yi Zhang; Lei Fan; Yingying Pei; Li Yu; Guanhua Xue; Lijuan Ma; Hongmei Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

5.  Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium.

Authors:  Oliver A Prince; Thomas M Krunkosky; Edward S Sheppard; Duncan C Krause
Journal:  Cell Microbiol       Date:  2017-12-22       Impact factor: 3.715

6.  Clinical differences between respiratory viral and bacterial mono- and dual pathogen detected among Singapore military servicemen with febrile respiratory illness.

Authors:  Zheng Jie Marc Ho; Xiahong Zhao; Alex R Cook; Jin Phang Loh; Sock Hoon Ng; Boon Huan Tan; Vernon J Lee
Journal:  Influenza Other Respir Viruses       Date:  2015-07       Impact factor: 4.380

Review 7.  The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae.

Authors:  Maureen H Diaz; Jonas M Winchell
Journal:  Front Microbiol       Date:  2016-03-08       Impact factor: 5.640

8.  Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection.

Authors:  Nouha Chaabane; Elisabeth Coupez; Matthieu Buscot; Bertrand Souweine
Journal:  Respir Med Case Rep       Date:  2016-12-06

9.  Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia.

Authors:  Maureen H Diaz; Kristen E Cross; Alvaro J Benitez; Lauri A Hicks; Preeta Kutty; Anna M Bramley; James D Chappell; Weston Hymas; Anami Patel; Chao Qi; Derek J Williams; Sandra R Arnold; Krow Ampofo; Wesley H Self; Carlos G Grijalva; Evan J Anderson; Jonathan A McCullers; Andrew T Pavia; Richard G Wunderink; Kathryn M Edwards; Seema Jain; Jonas M Winchell
Journal:  Open Forum Infect Dis       Date:  2016-03-30       Impact factor: 3.835

10.  The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014.

Authors:  Eun Ju Shin; Yunsun Kim; Jin-Young Jeong; Yu Mi Jung; Mi-Hee Lee; Eun Hee Chung
Journal:  Korean J Pediatr       Date:  2018-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.